NEWS: Spectral to complete development of melanoma detection product this month

 

http://www.healthimaging.com/index.php?view=article&id=23946%3Aspectral-to-complete-development-of-melanoma-detection-product-this-month&tmpl=component&print=1&page=&option=com_articles

 

 

Spectral to complete development of melanoma detection product this month

Spectral Molecular Imaging, a subsidiary of Cascade Technologies, will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September, ahead of schedule. According to Cascade, the device incorporates new advances in component technologies (optics, cameras, displays, embedded computers and software), as well as experience derived from previous prototypes developed under federal funding and tested in the clinic. The spectral range covered is also extended, now ranging from 385 nm to 920 nm. SkinSpect will be clinically tested on patients in early October at the University of Pittsburgh Medical Center Melanoma Center, said the Beverly Hills, Calif.-based Spectral. Last updated on September 3, 2010 at 8:46 am EST

 

Copyright © 2010 TriMed Media Group, Inc.

 

---

This message contains confidential information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this e-mail by mistake and delete this e-mail from your system. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this message, which arise as a result of e-mail transmission.